He also evaluates new technology, instruments and techniques to continually enhance the service XenoGesis delivers to clients, as well as expanding capabilities.
Pete is an experienced analytical project manager and brings almost 20 years’ combined DMPK experience. This was gained by working for CROs as a consultant and with large pharma companies including Sanofi and Organon, in both the discovery and development arenas. He joined XenoGesis in 2016.
With a speciality in mass spectrometry and bioanalysis, Pete has used his expertise in both large and small molecule analysis to deliver pre-clinical and clinical bioanalytical support to numerous drug projects.